TABLE 1

Clinical characteristics

PCOSControlP
n1013NS
Age (years)29 ± 333 ± 30.001
BMI (kg/m2)23.1 ± 3.223.8 ± 2.9NS
WHR0.81 ± 0.070.76 ± 0.05NS
FS-FSH (IU/l)4.7 ± 2.63.5 ± 1.6NS
FS-LH (IU/l)11.1 ± 5.43.2 ± 2.50.004
FS-LH/FS-FSH2.8 ± 1.61.2 ± 1.30.02
FS-DHEAS (umol/l)6.0 ± 4.03.3 ± 1.4NS
FS-Prolactin (μg/l)12.7 ± 6.39.8 ± 5.8NS
FS-GH (μg/l)3.2 ± 7.74.3 ± 4.4NS
FS-Cortisol326 ± 122316 ± 67NS
FS-Testosterone (nmol/l)2.5 ± 2.01.2 ± 0.3NS
FS-SHBG36 ± 1667 ± 280.01
T/SHBG0.070 ± 0.0410.022 ± 0.0120.004
FS-17-OPH (nmol/l)4.2 ± 2.92.2 ± 1.5NS
FP-Cholesterol (mmol/l)5.1 ± 0.94.6 ± 0.5NS
FP-HDL cholesterol (mmol/l)1.3 ± 0.41.6 ± 0.3NS
FP-Triglycerides (mmol/l)1.4 ± 1.50.8 ± 0.2NS
FS-Insulin (mU/l)6.95 ± 2.176.27 ± 0.96NS
FB-Glucose (mmol/l)4.76 ± 0.224.82 ± 0.42NS
Kitt (4–16 min)4.71 ± 0.875.50 ± 0.590.03
% Visceral fat26 ± 925 ± 9NS
% Subcutaneous fat71 ± 972 ± 9NS
Fat cell volume (pl)211 ± 112168 ± 91NS
  • All values are means ± SD. Groups were compared using Student’s unpaired two-tailed t test. FSH, follicle-stimulating hormone; LH, leutinizing hormone; Kitt (4–16 min) = % reduction of glucose concentration per minute in the insulin tolerance test (ITT); NS, not significant. DHEAS, dihydroepiandeterone; FB, fasting blood; FP, fasting plasma; FS, fasting serum; OPH, alpha hydroxiprogesterone; T, testosterone.